Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria

CONCLUSION: ACEi/ARB therapy was suboptimal in patients with diabetes, hypertension, and albuminuria. Non-adherence was associated with CKD stage, possibly because of concerns about adverse events and healthcare-related factors.PMID:38606848 | DOI:10.5414/CN111247

Source: Clinical Nephrology - April 12, 2024 Category: Urology & Nephrology Authors: Kittiphan Chienwichai Phirada Chaloemwa Sorawat Sangkaew Arunchai Chang Source Type: research